Majid Ghoddusi

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Qing Sheng, Joseph A D'Alessio, Daniel L Menezes, Christopher Karim, Yan Tang, Angela Tam, Suzanna Clark, Chi Ying, Anu Connor, Keith G Mansfield, Jean-Michel Rondeau, Majid Ghoddusi, Felipe C Geyer, Jane Gu, Margaret E McLaughlin, Rick Newcombe, GiNell Elliot, William R Tschantz, Sylvie Lehmann, Christie P Fanton, Kathy Miller, Thomas Huber, Katherine G Rendahl, Ursula Jeffry, Nancy K Pryer, Emma Lees, Paul Kwon, Judith A Abraham, Jason S Damiano, Tinya J Abrams
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies. Molecular cancer therapeutics 20 (7) (2021)
Eric L Smith, Kim Harrington, Mette Staehr, Reed Masakayan, Jon Jones, Thomas J Long, Khong Y Ng, Majid Ghoddusi, Terence J Purdon, Xiuyan Wang, Trevor Do, Minh Thu Pham, Jessica M Brown, Carlos Fernandez De Larrea, Eric Olson, Elizabeth Peguero, Pei Wang, Hong Liu, Yiyang Xu, Sarah C Garrett-Thomson, Steven C Almo, Hans-Guido Wendel, Isabelle Riviere, Cheng Liu, Blythe Sather, Renier J Brentjens
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells. Science translational medicine 11 (485) (2020)

Majid Ghoddusi.css-eqlu8i{font-size:small;padding-left:4px;}